Vaxcyte, Inc. (PCVX)
62.03
-0.58
(-0.93%)
USD |
NASDAQ |
Oct 30, 16:00
62.02
-0.02
(-0.02%)
After-Hours: 20:00
Vaxcyte 30-Day Average Daily Volume : 3.169M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 3.169M |
| October 29, 2026 | 3.202M |
| October 28, 2026 | 3.179M |
| October 27, 2026 | 3.146M |
| October 26, 2026 | 3.123M |
| October 23, 2026 | 3.122M |
| October 22, 2026 | 3.109M |
| October 21, 2026 | 3.055M |
| October 20, 2026 | 2.986M |
| October 19, 2026 | 2.955M |
| October 16, 2026 | 2.903M |
| October 15, 2026 | 2.819M |
| October 14, 2026 | 2.772M |
| October 13, 2026 | 2.769M |
| October 12, 2026 | 2.739M |
| October 09, 2026 | 2.683M |
| October 08, 2026 | 2.558M |
| October 07, 2026 | 2.459M |
| October 06, 2026 | 2.114M |
| October 05, 2026 | 1.798M |
| October 02, 2026 | 1.338M |
| October 01, 2026 | 1.283M |
| September 30, 2026 | 1.292M |
| September 29, 2026 | 1.265M |
| September 28, 2026 | 1.239M |
| Date | Value |
|---|---|
| September 25, 2026 | 1.199M |
| September 24, 2026 | 1.196M |
| September 23, 2026 | 1.175M |
| September 22, 2026 | 1.146M |
| September 21, 2026 | 1.134M |
| September 18, 2026 | 1.139M |
| September 17, 2026 | 1.091M |
| September 16, 2026 | 1.077M |
| September 15, 2026 | 1.065M |
| September 14, 2026 | 1.028M |
| September 11, 2026 | 1.006M |
| September 10, 2026 | 977561.9 |
| September 09, 2026 | 976946.8 |
| September 08, 2026 | 980490.4 |
| September 04, 2026 | 980001.8 |
| September 03, 2026 | 984469.6 |
| September 02, 2026 | 984933.9 |
| September 01, 2026 | 985426.8 |
| August 31, 2026 | 965804.2 |
| August 28, 2026 | 936521.5 |
| August 27, 2026 | 948783.7 |
| August 26, 2026 | 963400.0 |
| August 25, 2026 | 962245.7 |
| August 24, 2026 | 947667.9 |
| August 21, 2026 | 953300.1 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Moderna, Inc. | 18.56M |
| Vir Biotechnology, Inc. | 1.835M |
| Anavex Life Sciences Corp. | 1.310M |
| Revolution Medicines, Inc. | 2.014M |
| Foghorn Therapeutics, Inc. | 1.148M |